| 71 |
increased |
Disease Susceptibility
(MESH:D004198)
|
|
323: Increased, Disease susceptibility
|
| 72 |
increased |
DNA alkylation
(GO:0006305)
|
deoxyribonucleic acid
(CHEBI:16991)
|
97: Alkylation, DNA
|
| 73 |
increased |
mutation
(MESH:D009154)
|
deoxyribonucleic acid
(CHEBI:16991)
|
3 Events
|
| 76 |
increased |
|
acetylcholine
(CHEBI:15355)
|
10: Acetylcholine accumulation in synapses
|
| 77 |
increased |
|
atrioventricular block
(MESH:D054537)
|
444: Increased, Atrioventricular block and bradycardia
|
| 78 |
increased |
|
decreased heart rate
(MESH:D001919)
|
444: Increased, Atrioventricular block and bradycardia
|
| 79 |
increased |
respiratory distress
(MP:0001954)
|
|
445: Respiratory distress/arrest
|
| 80 |
increased |
ataxia
(MP:0001393)
|
|
3 Events
|
| 81 |
increased |
hyperactivity
(MP:0001399)
|
|
3 Events
|
| 82 |
increased |
paralysis
(MP:0000753)
|
|
5 Events
|
| 88 |
increased |
neuron death in response to oxidative stress
(GO:0036475)
|
|
191: Neuronal dysfunction
|
| 89 |
increased |
peroxisome proliferator activated receptor signaling pathway
(GO:0035357)
|
peroxisome proliferator-activated receptor alpha
(PR:000013056)
|
227: Activation, PPARα
|
| 101 |
increased |
aryl hydrocarbon receptor activity
(GO:0004874)
|
aryl hydrocarbon receptor
(PR:000003858)
|
18: Activation, AhR
|
| 106 |
increased |
gene expression
(GO:0010467)
|
prostaglandin G/H synthase 2
(PR:000013428)
|
1269: Increase, COX-2 expression
|
| 107 |
increased |
androgen receptor activity
(GO:0004882)
|
androgen receptor
(PR:000004191)
|
25: Agonism, Androgen receptor
|
| 117 |
increased |
|
calcium ion
(CHEBI:39124)
|
50: Increase, Ca++ (intracellular)
|
| 120 |
increased |
reactive oxygen species biosynthetic process
(GO:1903409)
|
reactive oxygen species
(CHEBI:26523)
|
1115: Increase, Reactive oxygen species
|
| 123 |
increased |
oxidative stress
(MP:0003674)
|
|
3 Events
|
| 125 |
increased |
gene expression
(GO:0010467)
|
bile acid receptor
(PR:000011396)
|
288: Activation of specific nuclear receptors, Transcriptional change
|
| 126 |
increased |
|
bile
(UBERON:0001970)
|
214: Bile accumulation, Pathological condition
|
| 127 |
increased |
cytokine secretion
(GO:0050663)
|
Cytokine
(FMA:84050)
|
87: Release, Cytokine
|
| 128 |
increased |
inflammatory response
(GO:0006954)
|
|
5 Events
|
| 137 |
increased |
estrogen receptor activity
(GO:0030284)
|
estrogen receptor
(PR:000007204)
|
3 Events
|
| 138 |
increased |
|
vitellogenins
(MESH:D014819)
|
2 Events
|
| 139 |
increased |
gene expression
(GO:0010467)
|
vitellogenins
(MESH:D014819)
|
2 Events
|